Works matching IS 02770008 AND DT 2024 AND VI 44 AND IP 9
Results: 13
Real‐world effectiveness of monoclonal antibody inhibitors of PCSK9 in patients with heterozygous familial hypercholesterolemia: A retrospective cohort study.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 730, doi. 10.1002/phar.4609
- By:
- Publication type:
- Article
Influence of intravenous iron on bacterial infection risk immediately following kidney transplantation.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 722, doi. 10.1002/phar.4608
- By:
- Publication type:
- Article
Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 738, doi. 10.1002/phar.4607
- By:
- Publication type:
- Article
The gray area of scientific adequacy.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 696, doi. 10.1002/phar.4606
- By:
- Publication type:
- Article
The power and pitfalls of underpowered studies.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 698, doi. 10.1002/phar.4605
- By:
- Publication type:
- Article
Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 701, doi. 10.1002/phar.4604
- By:
- Publication type:
- Article
Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 711, doi. 10.1002/phar.4603
- By:
- Publication type:
- Article
Correction to "Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐based study using the Clinical Practice Research Datalink"
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 766, doi. 10.1002/phar.2951
- Publication type:
- Article
Correction to "Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase producing Enterobacterales (ESBL‐E)"
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 760, doi. 10.1002/phar.2927
- Publication type:
- Article
Correction to "International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists"
- Published in:
- 2024
- Publication type:
- Correction Notice
ERRATUM.
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction to "Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis".
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 753, doi. 10.1002/phar.2846
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacotherapy, 2024, v. 44, n. 9, p. 693, doi. 10.1002/phar.2698
- Publication type:
- Article